Maciej Banach Selected Research

Non-alcoholic Fatty Liver Disease

1/2023	Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).
1/2023	Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?
10/2022	The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition.
3/2022	Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis.
6/2021	Targeting AMPK by Statins: A Potential Therapeutic Approach.
12/2020	Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study.
9/2019	Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease.
1/2019	Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey.
1/2019	A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study.
1/2018	Resveratrol effect on patients with non-alcoholic fatty liver disease: A matter of dose and treatment length.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maciej Banach Research Topics

Disease

124	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2008
73	Atherosclerosis 01/2024 - 02/2009
59	Inflammation (Inflammations) 01/2023 - 01/2006
57	Hypertension (High Blood Pressure) 01/2024 - 10/2005
43	Heart Failure 12/2023 - 06/2005
35	Stroke (Strokes) 01/2022 - 12/2005
34	Dyslipidemias (Dyslipidemia) 12/2023 - 12/2009
32	COVID-19 05/2023 - 01/2020
27	Type 2 Diabetes Mellitus (MODY) 09/2024 - 07/2007
26	Hypercholesterolemia 01/2024 - 12/2007
26	Chronic Renal Insufficiency 01/2023 - 05/2009
25	Atrial Fibrillation 09/2021 - 04/2006
23	Diabetes Mellitus 02/2024 - 12/2007
23	Insulin Resistance 01/2024 - 11/2011
23	Neoplasms (Cancer) 01/2023 - 01/2011
23	Myocardial Infarction 01/2023 - 10/2008
22	Coronary Artery Disease (Coronary Atherosclerosis) 09/2024 - 02/2009
22	Obesity 01/2023 - 11/2011
17	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2024 - 01/2017
17	Acute Coronary Syndrome 11/2023 - 10/2008
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 02/2009
12	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2015
12	Muscular Diseases (Myopathy) 01/2021 - 01/2015
11	Coronary Disease (Coronary Heart Disease) 01/2023 - 10/2006
11	Hemorrhage 01/2023 - 12/2009
11	Infections 01/2022 - 09/2013
11	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2004
10	Body Weight (Weight, Body) 09/2022 - 01/2014
9	Hyperlipidemias (Hyperlipidemia) 10/2022 - 09/2013
9	Thrombosis (Thrombus) 12/2021 - 04/2009
9	Myalgia 09/2021 - 01/2015
8	Ischemic Stroke 01/2022 - 10/2016
7	Fatty Liver 01/2023 - 12/2018
7	Breast Neoplasms (Breast Cancer) 08/2022 - 05/2012
7	Kidney Diseases (Kidney Disease) 06/2017 - 11/2010
6	Rupture 09/2022 - 11/2018
6	Fibrosis (Cirrhosis) 03/2022 - 01/2017
6	Cognitive Dysfunction 01/2021 - 09/2014
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2020 - 04/2007
6	Sepsis (Septicemia) 11/2019 - 01/2006
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 01/2006
5	Hyperglycemia 03/2024 - 09/2020
5	ST Elevation Myocardial Infarction 02/2024 - 11/2009
5	Rhabdomyolysis 11/2023 - 06/2016
5	Vascular Diseases (Vascular Disease) 01/2023 - 07/2018

Drug/Important Bio-Agent (IBA)

115	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 12/2005
112	LipidsIBA 09/2024 - 12/2005
62	oxidized low density lipoproteinIBA 05/2024 - 01/2013
51	LDL CholesterolIBA 01/2024 - 01/2013
49	CholesterolIBA 09/2024 - 12/2005
32	Biomarkers (Surrogate Marker)IBA 09/2024 - 09/2012
26	Triglycerides (Triacylglycerol)IBA 09/2022 - 01/2013
23	C-Reactive ProteinIBA 01/2023 - 07/2007
23	HDL CholesterolIBA 01/2023 - 10/2012
21	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 12/2013
20	Lipoproteins (Lipoprotein)IBA 05/2024 - 12/2005
19	AntioxidantsIBA 04/2023 - 09/2007
18	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2009
15	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 12/2012
14	Lipoprotein(a)IBA 01/2024 - 09/2015
14	EnzymesIBA 04/2023 - 01/2004
14	CurcuminIBA 01/2023 - 01/2016
13	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2024 - 10/2018
13	AdipokinesIBA 12/2022 - 11/2011
13	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2013
12	VaccinesIBA 01/2024 - 05/2019
12	Insulin (Novolin)FDA Link 01/2023 - 11/2011
11	PCSK9 InhibitorsIBA 01/2023 - 01/2017
11	ApolipoproteinsIBA 01/2022 - 12/2014
11	HDL LipoproteinsIBA 01/2021 - 08/2014
10	Apolipoproteins B (ApoB)IBA 10/2022 - 12/2014
10	LeptinIBA 10/2021 - 11/2011
9	CytokinesIBA 01/2023 - 01/2004
9	Interleukin-6 (Interleukin 6)IBA 12/2022 - 06/2009
9	pro-brain natriuretic peptide (1-76)IBA 11/2022 - 01/2006
9	AdiponectinIBA 10/2021 - 11/2011
8	Ezetimibe (Zetia)FDA Link 12/2023 - 01/2016
8	Therapeutic UsesIBA 05/2023 - 01/2016
8	Proprotein Convertase 9IBA 02/2023 - 01/2017
8	Warfarin (Coumadin)FDA LinkGeneric 06/2020 - 10/2008
7	MicroRNAs (MicroRNA)IBA 09/2024 - 01/2016
7	Atorvastatin (Lipitor)FDA Link 01/2021 - 10/2006
7	Vitamin D FDA LinkGeneric 05/2020 - 01/2015
6	red yeast riceIBA 02/2024 - 01/2017
6	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2018
6	ResveratrolIBA 12/2022 - 10/2017
6	Natriuretic PeptidesIBA 01/2022 - 10/2005
6	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2018
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2021 - 12/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 01/2006
6	ResistinIBA 09/2019 - 11/2011
5	Oxygen (Dioxygen)IBA 01/2023 - 07/2021
5	Hormones (Hormone)IBA 08/2022 - 10/2005

Therapy/Procedure

109	Therapeutics 05/2024 - 10/2006
14	Telerehabilitation 12/2023 - 11/2019
11	Secondary Prevention 07/2023 - 09/2014
9	Drug Therapy (Chemotherapy) 12/2022 - 08/2009
6	Percutaneous Coronary Intervention 02/2023 - 06/2009
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2020 - 04/2006
6	Renal Dialysis (Hemodialysis) 06/2015 - 01/2006